neo-gambogic acid has been researched along with 4-phenylbutylamine in 1 studies
| Studies (neo-gambogic acid) | Trials (neo-gambogic acid) | Recent Studies (post-2010) (neo-gambogic acid) | Studies (4-phenylbutylamine) | Trials (4-phenylbutylamine) | Recent Studies (post-2010) (4-phenylbutylamine) |
|---|---|---|---|---|---|
| 63 | 0 | 59 | 109 | 2 | 99 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, J; Li, J; Li, Y; Liu, B; Qiu, J; Wang, D; Wu, J; Xie, R; Zhou, J | 1 |
1 other study(ies) available for neo-gambogic acid and 4-phenylbutylamine
| Article | Year |
|---|---|
Gambogenic acid induces apoptosis and autophagy through ROS-mediated endoplasmic reticulum stress via JNK pathway in prostate cancer cells.
Topics: Acetylcysteine; Apoptosis; Autophagy; Cell Line, Tumor; Endoplasmic Reticulum Stress; Humans; Male; MAP Kinase Signaling System; Prostatic Neoplasms; Reactive Oxygen Species | 2023 |